# Rahul Banerjee
פרקי פודקאסט מובילים
מְעוּדכָּן:
Arunoday Banerjee, known as "Rahul", (born 16 October 1983), is a Indian Bengali male actor. He has worked in films and TV. Banerjee made his stage appearance at the age of three with his father’s (Biswanath Banerjee) theater troupe Bijoygarh Atmaprakash play entitled Raj Darshan. Since then, he has acted in almost 450 stage shows, with his father’s troupe and with Theatron.
The Data Problem in T-Cell Lymphoma Care
In this episode of TheHemOnc Pulse, Rahul Banerjee, MD, speaks with Francine Foss, MD, professor of medicine and dermatology at Yale School of Medicine, about the evolving landscape of T-cell lymphomas. Dr Foss discusses the unique challenges of studying and treating rare diseases such as cutaneou…
S1 Ep211: Exploring and Managing Gastrointestinal-Related CAR T-Cell Lymphomas
In a special cobranded episode between Oncology On the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks, host Rahul Banerjee, MD, FACP, spoke with colleague Hitomi Hosoya, MD, PhD, about a study she and coauthors publis…
Exploring and Managing Gastrointestinal-Related CAR T-Cell Lymphomas
In a special cobranded episode between Oncology on the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks, host Rahul Banerjee, MD, FACP, spoke with colleague Hitomi Hosoya, MD, PhD, about a study she and coauthors publishe…
Community-Based CAR-T Therapy: Expanding Access, Navigating Challenges
In this episode of HemOnc Pulse, host Dr. Rahul Banerjee of Fred Hutchinson Cancer Center sits down with Dr. Gary Simmons, a hematologist-oncologist at Virginia Oncology Associates, to explore the evolving role of community-based cellular therapy programs and the future of patient access to innova…
Precision Decisions in NDMM: Live Virtual Rounds Preview
Frontline treatment selection for newly diagnosed multiple myeloma (NDMM) is more complex than ever. With quadruplet regimens and anti-CD38 antibodies redefining the landscape, how do you choose the right therapy for each unique patient?
In this exclusive preview, Ashley Chen, PharmD, BCOP (Fred …
Precision Decisions in NDMM: Live Virtual Rounds Preview
Frontline treatment selection for newly diagnosed multiple myeloma (NDMM) is more complex than ever. With quadruplet regimens and anti-CD38 antibodies redefining the landscape, how do you choose the right therapy for each unique patient?
In this exclusive preview, Ashley Chen, PharmD, BCOP (Fred …
EHA2026 Multiple Myeloma Highlights: CEPHEUS, MajesTEC-3, MajesTEC-9, MonumenTAL-3, SUCCESSOR-2
Welcome back to the Oncology Brothers podcast! In this episode, we were joined by Dr. Rahul Banerjee, a myeloma specialist from the Fred Hutch Cancer Center, to discuss the latest updates in multiple myeloma from EHA 2026.
Join us as we dived into:
The CEPHEUS study update, reaffirming the …
Taking Bispecific Antibodies Outpatient: Lessons From the Front Lines
How can bispecific antibodies be safely delivered outside the hospital? Rahul Banerjee, MD and Ajay Nooka, MD discuss outpatient step-up dosing, prophylactic tocilizumab, CRS management, and practical tips for implementing bispecific therapy in academic and community practice.
Sequencing therapies in multiple myeloma: navigating an expanding treatment landscape
This VJHemOnc podcast explores the evolving treatment landscape in multiple myeloma, focusing on treatment selection and sequencing across the disease course. Fredrik Schjesvold, MD, PhD, Oslo University Hospital, Oslo, Norway, discusses shared decision-making in frontline treatment, while Peter V…
The Transformative Potential of AI in Hematologic Malignancies
How is AI transforming hematologic cancer care? In this episode of The HemOnc Pulse, Rahul Banerjee, MD, of the Fred Hutchinson Cancer Institute, interviews Louis Williams of Cleveland Clinic on this topic. Together, the experts explore AI scribes, machine learning, genomic data, early detection, …
מנוע חיפוש PODCAST
אתה יכול להשתמש באתר שלנו כדי לחפש3,829,527פודקאסטים ופודקאסטים196,510,876לפי אנשים, מקומות או נושאים.
השקעה בידע מניבה את התשואה הטובה ביותר, ולכן אני מאזין לפודקאסטים.
‐ Benjamin "Llamacorn" Franklin
